A round burgundy crest emblem with simple gold ring detailing, plain and formal in style
A wide horizontal photograph of mountain scenery near Banff with pale turquoise sky, dark evergreen slopes, and a soft muted mood
A round burgundy crest emblem mirroring the first, with plain gold ring detailing and a formal quiet mood

Annual Scientific Meeting of the Canadian Organization of Medical Physicists — July 9–12, 2014, The Banff Centre, Banff, Alberta, Canada

Hypofractionation for prostate cancer from a physics perspective

Hypofractionation has become one of the most discussed shifts in prostate cancer radiotherapy over the past decade, and medical physicists sit at the centre of making it work safely. Delivering larger doses per fraction over fewer visits changes the radiobiology, the planning assumptions, and the demands on treatment verification in equal measure.

For physicists in Australian centres, the conversation is rarely theoretical. Departments in Sydney, Melbourne, Brisbane, and Perth have moved moderate hypofractionation into routine practice, and ultra-hypofractionated regimens are catching up. Reimbursement through the Medicare Benefits Schedule and the realities of public hospital throughput shape which schedules a department can actually adopt.

This piece walks through the radiobiological rationale, the dose-calculation and IGRT requirements, and the commissioning lessons that have emerged as hypofractionation has matured. It is written for physics teams looking for a tidy summary of the moving parts rather than a clinical opinion piece.

The radiobiological rationale for hypofractionation

The argument for prostate hypofractionation rests on the low α/β ratio estimated for prostate adenocarcinoma, generally placed between 1.5 and 3 Gy. Late-responding rectal and bladder mucosa sit closer to 3 to 5 Gy, so the differential favours larger fractions when tumour control is weighed against late toxicity.

The linear-quadratic model gives a clean way to compare schedules. It explains why 60 Gy in 20 fractions or 36.25 Gy in 5 fractions can be biologically equivalent to 78 Gy in 39 fractions for tumour kill while keeping late effects comparable. The caveats are real: large fraction sizes, SBRT in particular, sit at the edge of where the LQ model is trusted, and repair half-times in prostate tissue remain a live research question.

A useful sanity check is to convert any proposed schedule into an EQD2 for both tumour and late rectal tissue and confirm the therapeutic ratio survives the conversion. Most published regimens clear that bar, but exotic schedules should be checked before commissioning time is committed.

Treatment planning and dose calculation workflows

Shifting to hypofractionation rarely means rebuilding the planning chain, but it does expose hidden assumptions. PTV margins can usually shrink when daily image guidance is in place, and that only works if residual systematic error has been properly audited. A 3 mm margin that looked generous for 78 Gy feels tight when it carries a 36.25 Gy SBRT course, where any cold spot stays around longer.

Dose calculation algorithms matter more at extreme hypofractionation. Type-b algorithms such as Acuros XB or grid-based Boltzmann solvers give cleaner behaviour in heterogeneous regions and are preferred across most Australian centres. Pencil beam convolution is effectively retired. Commissioning beam data, profile reproducibility, and small-field output factors all deserve another look when stepping from conventional IMRT to SBRT.

Small-field dosimetry deserves particular attention when transitioning to SBRT. Output factors and beam profile measurements at small cones or MLC-defined fields behave differently from open fields, and the beam model should be revalidated with formal measurements on each field size used clinically.

Motion management and image-guided delivery

Prostate motion is one reason hypofractionation took so long to gain traction. The gland drifts with rectal filling, breathing, and pelvic muscle relaxation, sometimes by more than a centimetre during a single fraction. Across 39 visits the dose averages out, but with five fractions the worst deliveries dominate the outcome.

Modern image guidance softens this problem. Daily CBCT with soft-tissue matching, fiducial marker tracking, or surface guidance reduces systematic error meaningfully, and intra-fraction monitoring with kV imaging or transperineal ultrasound catches drift mid-arc. Australian SBRT programmes usually standardise on a tight bladder and bowel preparation protocol, often paired with a 5 mm PTV expansion and a five-minute imaging cadence before each arc. Competency assessment sits alongside the technology choices, because nothing else matters if staff cannot recognise poor matches.

Where SBRT programmes have struggled in their first year, the cause is almost always a softer motion-management protocol than expected. A reproducible prep procedure paired with a visible feedback loop when preparation slips tends to matter more than any new hardware purchase.

Commissioning and quality assurance demands

Every step up in dose per fraction tightens the QA budget. Winston-Lutz tests, plan-specific QA, and independent secondary dose calculations all carry more weight when a single delivery error translates into a larger biological hit. End-to-end testing on an anthropomorphic phantom, including imaging and registration, has become the floor rather than the ceiling.

For physicists running brachytherapy alongside external beam, the workflow overlaps in interesting ways. The community is updating how TG-43-based calculations are validated against model-based algorithms, and recent reviews collate those TG-43 brachytherapy updates in a usable format. LDR and HDR programmes push the same validation culture as SBRT, and vendors now offer end-to-end brachytherapy QA phantoms that fit into existing linac schedules. Independent peer review of every plan, including hypofractionated ones, should be the default.

Dosimetric auditing through independent external review, including formal phantom audits, has become more common across Australian hypofractionated programmes. The audit culture exports easily from the brachytherapy community and pays off quickly when commissioning new schedules.

Australian clinical context and local evidence

Australian practice is shaped by TROG-led trials and the ANZUP collaborative network. TROG 03.04 RADAR informed adjuvant prostate fractionation, and more recent studies have reported on stereotactic schedules in the Australian population. Centres such as Peter MacCallum, the Chris O'Brien Lifehouse, and the Royal Brisbane and Women's Hospital have contributed to that evidence, and physicists share templates through the ACPSEM special interest groups.

Reimbursement matters more than clinicians sometimes acknowledge. Reviews of the Medicare Benefits Schedule through the early 2010s left several hypofractionated schedules without a clean billing code, which pushed some departments to keep conventional fractionation for routine cases. The conversation has shifted since then, but physics leads planning a new service line still need to understand the funding pathway before locking in equipment purchases.

ANZUP-led work on functional imaging and PSMA-PET-driven planning is reshaping target-volume thinking. Hypofractionation increasingly lives downstream of contouring atlases and motion policies rather than driving them.

Practical recommendations for physics teams

A few habits tend to make hypofractionated programmes safer from day one. These are drawn from commissioning reports across several Australian centres and hold up across both SBRT and moderate hypofractionation.

  • Build the margin and IGRT audit before the first patient, not after the first reportable toxicity.
  • Run a documented end-to-end test for every new hypofractionated schedule, including imaging, registration, and delivery.
  • Cross-train brachytherapy physicists on external-beam QA, since the validation culture is the same.
  • Watch for rectal and bladder filling drift during treatment and intervene with a coaching protocol rather than accepting the plan as delivered.
  • Maintain independent secondary calculations for every fractionation class, including SBRT.
  • Apply peer review of plans with the same rigour as a radical course of conventional IMRT.
  • Document every deviation and near-miss in a way that feeds back into the centre's commissioning file.

Following these habits does not replace clinical judgement, but it gives physicists a defensible baseline for the conversations that come up at audit. New staff can be trained against the list, and the items can be cross-referenced against departmental SOPs when deviations occur.

For teams preparing for the COMP 2014 Annual Scientific Meeting in Banff, the program offers a useful opportunity to discuss these challenges face-to-face with colleagues running similar services. Practical details around venue logistics and bookings are available through the conference accommodation page, which delegates are encouraged to consult before travel plans firm up.